Close

BioCryst Pharma (BCRX) PT Raised to $11 at RBC Capital

May 7, 2021 6:12 AM EDT Send to a Friend
RBC Capital analyst Brian Abraham ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login